Angiotensin-converting enzyme 2 in lung diseases
Top Cited Papers
- 30 June 2006
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Pharmacology
- Vol. 6 (3), 271-276
- https://doi.org/10.1016/j.coph.2006.03.001
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonistThorax, 2004
- Minireview: Overview of the Renin-Angiotensin System—An Endocrine and Paracrine SystemEndocrinology, 2003
- The angiotensin–converting enzyme gene family: genomics and pharmacologyTrends in Pharmacological Sciences, 2002
- Deletion Polymorphisms in the Angiotensin Converting Enzyme Gene Are Associated with Pulmonary Hypertension Evoked by Exercise Challenge in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertensionThe Journal of Pathology, 2000
- Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitorAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2000
- Modulation of Angiotensin II Receptor Expression during Development and Regression of Hypoxic Pulmonary HypertensionAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 1995
- Angiotensin II type-1 receptor subtype cDNAs: Differential tissue expression and hormonal regulationBiochemical and Biophysical Research Communications, 1992
- Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat.1975